Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AXDXNASDAQ:CLIRNASDAQ:DAIONASDAQ:PRPO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAXDXAccelerate Diagnostics$0.65$0.03▼$2.09$857K0.22532,775 shs53.64 million shsCLIRClearSign Technologies$0.54$0.61$0.46▼$1.72$28.16M1.191,255 shs131,778 shsDAIOData I/O$3.17+0.3%$2.70$1.88▼$3.23$29.20M0.9826,251 shs50,411 shsPRPOPrecipio$13.98+16.0%$9.64$3.90▼$15.10$18.22M1.2810,142 shs57,203 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAXDXAccelerate Diagnostics0.00%0.00%0.00%-93.02%-96.48%CLIRClearSign Technologies-7.87%-4.07%-18.62%+6.78%-39.04%DAIOData I/O-0.16%+2.26%+14.86%+47.44%+11.62%PRPOPrecipio+12.29%+26.63%+24.82%+161.31%+173.99%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAXDXAccelerate DiagnosticsN/AN/AN/AN/AN/AN/AN/AN/ACLIRClearSign Technologies1.7199 of 5 stars3.53.00.00.00.60.00.6DAIOData I/O2.6013 of 5 stars3.53.00.00.03.01.70.0PRPOPrecipioN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAXDXAccelerate Diagnostics 4.00Strong BuyN/AN/ACLIRClearSign Technologies 3.00Buy$2.00272.37% UpsideDAIOData I/O 3.00Buy$4.0026.18% UpsidePRPOPrecipio 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest PRPO, CLIR, DAIO, and AXDX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/17/2025CLIRClearSign TechnologiesHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$6.00 ➝ $2.00(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAXDXAccelerate Diagnostics$11.70M0.00N/AN/A($1.37) per share0.00CLIRClearSign Technologies$3.60M7.82N/AN/A$0.27 per share1.99DAIOData I/O$21.85M1.34N/AN/A$1.91 per share1.66PRPOPrecipio$20.03M1.06N/AN/A$8.16 per share1.71Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAXDXAccelerate Diagnostics-$61.62M-$2.34N/AN/AN/A-471.83%N/A-191.66%N/ACLIRClearSign Technologies-$5.30M-$0.12N/A53.71N/A-216.48%-44.36%-38.35%8/18/2025 (Estimated)DAIOData I/O-$3.09M-$0.29N/A∞N/A-12.21%-14.56%-10.84%7/24/2025 (Estimated)PRPOPrecipio-$4.29M-$2.07N/A∞N/A-15.45%-25.87%-17.93%8/11/2025 (Estimated)Latest PRPO, CLIR, DAIO, and AXDX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025PRPOPrecipioN/A-$0.59N/A-$0.59N/A$4.93 million4/24/2025Q1 2025DAIOData I/O-$0.09-$0.04+$0.05-$0.04$5.30 million$6.18 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAXDXAccelerate DiagnosticsN/AN/AN/AN/AN/ACLIRClearSign TechnologiesN/AN/AN/AN/AN/ADAIOData I/ON/AN/AN/AN/AN/APRPOPrecipioN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAXDXAccelerate DiagnosticsN/A1.501.34CLIRClearSign TechnologiesN/A5.635.63DAIOData I/ON/A4.203.04PRPOPrecipio0.030.760.57Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAXDXAccelerate Diagnostics17.14%CLIRClearSign Technologies24.03%DAIOData I/O36.95%PRPOPrecipio10.45%Insider OwnershipCompanyInsider OwnershipAXDXAccelerate Diagnostics43.60%CLIRClearSign Technologies4.96%DAIOData I/O2.60%PRPOPrecipio16.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAXDXAccelerate Diagnostics22025.21 million14.13 millionOptionableCLIRClearSign Technologies1052.42 million49.82 millionOptionableDAIOData I/O1009.24 million8.57 millionOptionablePRPOPrecipio601.51 million1.26 millionNo DataPRPO, CLIR, DAIO, and AXDX HeadlinesRecent News About These CompaniesPrecipio, Inc. Urges Shareholders to Vote by 11 PM Today for Quorum at Upcoming MeetingJune 16, 2025 | quiverquant.comQPrecipio, Inc. (NASDAQ:PRPO) Director Richard A. Sandberg Buys 1,399 SharesMay 31, 2025 | insidertrades.comInsider Buying: Precipio, Inc. (NASDAQ:PRPO) Director Purchases 8,035 Shares of StockMay 23, 2025 | insidertrades.comPrecipio, Inc. (NASDAQ:PRPO) Director Purchases $36,005.97 in StockMay 22, 2025 | insidertrades.comPrecipio, Inc. (NASDAQ:PRPO) Q1 2025 Earnings Call TranscriptMay 17, 2025 | msn.comPrecipio, Inc.: Precipio Announces its Q1-2025 Financial ResultsMay 15, 2025 | finanznachrichten.dePrecipio, Inc. Reports Strong Q1-2025 Financial Performance with 43% Revenue GrowthMay 14, 2025 | quiverquant.comQPrecipio Announces its Q1-2025 Financial ResultsMay 14, 2025 | globenewswire.comPrecipio Schedules Q1-2025 Shareholder Update CallMay 6, 2025 | tipranks.comPrecipio Announces Q1-2025 Shareholder Update CallMay 1, 2025 | globenewswire.comPrecipio Stock Price, Quotes and Forecasts | NASDAQ:PRPO | BenzingaApril 26, 2025 | benzinga.comPrecipio trading halted, volatility trading pauseApril 24, 2025 | markets.businessinsider.comEarnings call transcript: Precipio Q4 2024 sees revenue growth, strategic shiftsApril 2, 2025 | investing.comPrecipio Inc (PRPO) Q4 2024 Earnings Call Highlights: Break-Even Achieved and Strategic Growth ...April 2, 2025 | finance.yahoo.comPrecipio, Inc. (NASDAQ:PRPO) Q4 2024 Earnings Call TranscriptApril 1, 2025 | msn.comPrecipio Reports Positive Q4 Financial ResultsMarch 31, 2025 | tipranks.comPrecipio, Inc. (PRPO) Q4 2024 Earnings Call TranscriptMarch 31, 2025 | seekingalpha.comPrecipio, Inc. to Host Q4 and Year-End 2024 Corporate Update Call on March 31, 2025March 17, 2025 | quiverquant.comQPrecipio Announces Q4 and year-end 2024 Shareholder Update CallMarch 17, 2025 | globenewswire.comPrecipio achieves positive adjusted EBITDA, cash flow in Q4February 25, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePRPO, CLIR, DAIO, and AXDX Company DescriptionsAccelerate Diagnostics NASDAQ:AXDX$0.04 +0.04 (+∞) As of 05/14/2025 This is a fair market value price provided by Polygon.io. Learn more.Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.ClearSign Technologies NASDAQ:CLIR$0.54 0.00 (0.00%) As of 07/7/2025 04:00 PM EasternClearSign Technologies Corporation designs and develops products and technologies to enhance emission and operational performance, energy efficiency, emission reduction, safety, and overall cost-effectiveness of industrial and commercial systems in the United States, the People's Republic of China, and Hong Kong. The company's technologies include ClearSign core burner technology consists of an industrial burner body and a downstream porous ceramic or metal flame stabilizing structure; ClearSign core process burner technology that provides a direct burner replacement for traditional refinery process heaters; ClearSign core boiler burner technology; ClearSign core flaring burners that can be used individually, or in combination, to provide a flare product with extremely low nitrogen oxide emissions; and ClearSign eye flame sensor, an electrical flame sensor for industrial applications. It serves energy, institutional, commercial and industrial boiler, chemical, and petrochemical industries. The company was formerly known as ClearSign Combustion Corporation and changed its name ClearSign Technologies Corporation in November 2019. ClearSign Technologies Corporation was incorporated in 2008 and is headquartered in Tulsa, Oklahoma.Data I/O NASDAQ:DAIO$3.17 +0.01 (+0.32%) As of 07/7/2025 04:00 PM EasternData I/O Corporation, together with its subsidiaries, engages in the design, manufacture, and sale of programming and security deployment systems and services for electronic device manufacturers in the United States, Europe, and internationally. Its programming system products are used to program integrated circuits (ICs) with the specific data for the ICs. The company offers PSV handlers off-line automated programming systems, such as PSV2800 automated programming system which focuses on high-volume manufacturing in a lower cost platform; PSV7000 automated programming system for security deployment upgrades; PSV5000 automated programming system that combines mid-range capacity and supports security deployment; and PSV3500 automated programming system which provides basic programming needs. It also provides SentriX security deployment system; and LumenX and non-automated FlashPAK III programming systems. In addition, the company offers hardware support, system installation and repair, and device programming services. It markets and sells its products to original equipment manufacturers in automotive and consumer electronics, internet of things, and industrial, as well as electronic manufacturing service contract manufacturers through direct sales, and indirect sales representatives and distributors. Data I/O Corporation was incorporated in 1969 and is headquartered in Redmond, Washington.Precipio NASDAQ:PRPO$13.98 +1.93 (+16.02%) Closing price 07/7/2025 04:00 PM EasternExtended Trading$14.38 +0.40 (+2.90%) As of 07/7/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
